Back
Innate Pharma SA Stock Price Chart
Color-coded buy, sell, hold signals make stock decisions simple.
Get Your Free Stock Analysis Now
Sell
33
IPHA
Innate Pharma SA
Last Price:
$1.77
Seasonality Move:
-10.69%
7 Day Trial
ALL ACCESS PASS
$
7
Know when to buy, sell, or hold. Rate Any Stock In Seconds
Get Your Free Stock Analysis Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IPHA is experiencing slight selling pressure.
Innate Pharma SA Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.77 | Buy |
| 20-day SMA: | 1.76 | Buy |
| 50-day SMA: | 1.81 | Sell |
| 200-day SMA: | 1.98 | Sell |
| 8-day EMA: | 1.13 | Buy |
| 20-day EMA: | 0.59 | Buy |
| 50-day EMA: | 0.26 | Buy |
| 200-day EMA: | 0.07 | Buy |
Innate Pharma SA Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.4 | Buy |
| Relative Strength Index (14 RSI): | 49.36 | Sell |
| Chaikin Money Flow: | -2375 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.73 - 1.79) | Buy |
| Bollinger Bands (100): | (1.77 - 2.05) | Sell |
Innate Pharma SA Technical Analysis
| Jan 14 | Jan 15 | Jan 16 | Jan 20 | Jan 21 | Jan 22 | Jan 23 | Jan 26 | Jan 27 | Jan 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 14 | 15 | 16 | 20 | 21 | 22 | 23 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Innate Pharma SA Stock
Is Innate Pharma SA Stock a Buy?
-
Innate Pharma SA share price is 1.78 while IPHA 8-day simple moving average is 1.77, which is a Buy signal.
-
The stock price of IPHA is 1.78 while Innate Pharma SA 20-day SMA is 1.76, which makes it a Buy.
-
Innate Pharma SA 50-day simple moving average is 1.81 while IPHA share price is 1.78, making it a Sell technically.
-
IPHA stock price is 1.78 and Innate Pharma SA 200-day simple moving average is 1.98, creating a Sell signal.
IPHA Technical Analysis vs Fundamental Analysis
Sell
33
Innate Pharma SA (IPHA)
is a Sell
Is Innate Pharma SA a Buy or a Sell?
-
Innate Pharma SA stock is rated a SellThe current Innate Pharma SA [IPHA] share price is $1.78. The Score for IPHA is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
Innate Pharma SA Stock Info
Market Cap:
166.8M
Price in USD:
1.78
Share Volume:
8.7K
Innate Pharma SA 52-Week Range
52-Week High:
2.63
52-Week Low:
1.63
Sell
33
Innate Pharma SA (IPHA)
is a Sell
Innate Pharma SA Share Price Forecast
-
What is the Innate Pharma SA stock price today?The Innate Pharma SA stock price is 1.78 USD today.
-
Will IPHA stock go up or go down?Innate Pharma SA> share price is forecast to RISE/FALL based on technical indicators
-
Is Innate Pharma SA overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Innate Pharma SA is overvalued.
Is Innate Pharma SA Stock a Buy?
-
Innate Pharma SA share price is 1.78 while IPHA 8-day exponential moving average is 1.13, which is a Buy signal.
-
The stock price of IPHA is 1.78 while Innate Pharma SA 20-day EMA is 0.59, which makes it a Buy.
-
Innate Pharma SA 50-day exponential moving average is 0.26 while IPHA share price is 1.78, making it a Buy technically.
-
IPHA stock price is 1.78 and Innate Pharma SA 200-day simple moving average is 0.07, creating a Buy signal.
Fundamental Analysis of Innate Pharma SA
Is Innate Pharma SA a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and a decrease next year of $0.16 per share.
Technical Analysis of Innate Pharma SA
Should I short Innate Pharma SA stock?
-
IPHA Moving Average Covergence Divergence (MACD) indicator is 0.4, suggesting Innate Pharma SA is a Buy
-
Innate Pharma SA Relative Strength Index (RSI) is 49.36, which suggest Innate Pharma SA is oversold
-
The Bollinger Bands (25) for Innate Pharma SA is (1.73 - 1.79), which suggest Innate Pharma SA is a Sell
-
The Bollinger Bands (100) for Innate Pharma SA is (1.77 - 2.05), which suggest Innate Pharma SA is a Sell
* Innate Pharma SA stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.